Crystal Structure of IMP-2 Metallo-β-lactamase from Acinetobacter spp. : Comparison of Active-Site Loop Structures between IMP-1 and IMP-2
-
- Yamaguchi Yoshihiro
- Environmental Safety Center, Kumamoto University
-
- Matsueda Satoshi
- Graduate School of Pharmaceutical Sciences, Kumamoto University
-
- Matsunaga Kazuyo
- Graduate School of Pharmaceutical Sciences, Kumamoto University
-
- Takashio Nobutoshi
- Graduate School of Pharmaceutical Sciences, Kumamoto University
-
- Toma-Fukai Sachiko
- Graduate School of Pharmaceutical Sciences, The University of Tokyo
-
- Yamagata Yuriko
- Graduate School of Pharmaceutical Sciences, Kumamoto University
-
- Shibata Naohiro
- Department of Bacterial Pathogenesis and Infection Control, National Institute of Infectious Diseases
-
- Wachino Jun-ichi
- Department of Bacteriology, Nagoya University Graduate School of Medicine
-
- Shibayama Keigo
- Department of Bacterial Pathogenesis and Infection Control, National Institute of Infectious Diseases
-
- Arakawa Yoshichika
- Department of Bacteriology, Nagoya University Graduate School of Medicine
-
- Kurosaki Hiromasa
- Graduate School of Pharmaceutical Sciences, Kumamoto University
書誌事項
- タイトル別名
-
- Crystal Structure of IMP-2 Metallo-β-lactamase from <i>Acinetobacter</i> spp.
- Crystal Structure of IMP-2 Metallo-β-lactamase from Acinetobacter spp.
- Comparison of Active-Site Loop Structures between IMP-1 and IMP-2
この論文をさがす
抄録
IMP-2, a subclass B1 metallo-β-lactamase (MBL), is a Zn(II)-containing hydrolase. This hydrolase, involved in antibiotic resistance, catalyzes the hydrolysis of the C–N bond of the β-lactam ring in β-lactam antibiotics such as benzylpenicillin and imipenem. The crystal structure of IMP-2 MBL from Acinetobacter spp. was determined at 2.3 Å resolution. This structure is analogous to that of subclass B1 MBLs such as IMP-1 and VIM-2. Comparison of the structures of IMP-1 and IMP-2, which have an 85% amino acid identity, suggests that the amino acid substitution at position 68 on a β-strand (β3) (Pro in IMP-1 versus Ser in IMP-2) may be a staple factor affecting the flexibility of loop 1 (comprising residues at positions 60–66; EVNGWGV). In the IMP-1 structure, loop 1 adopts an open, disordered conformation. On the other hand, loop 1 of IMP-2 forms a closed conformation in which the side chain of Trp64, involved in substrate binding, is oriented so as to cover the active site, even though there is an acetate ion in the active site of both IMP-1 and IMP-2. Loop 1 of IMP-2 has a more flexible structure in comparison to IMP-1 due to having a Ser residue instead of the Pro residue at position 68, indicating that this difference in sequence may be a trigger to induce a more flexible conformation in loop 1.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 38 (1), 96-101, 2015
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204631182592
-
- NII論文ID
- 130004872220
-
- NII書誌ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 026001010
-
- PubMed
- 25744464
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可